Home › Kanser ng Endometrium › Idaho
Pag-aaral pangklinika para sa Kanser ng Endometrium sa Idaho
5 pag-aaral para sa Kanser ng Endometrium ang naghahanap ng mga kalahok sa mga site sa Idaho.
Mga Lungsod sa Idaho
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Kootenai Clinic Cancer Services - Post Falls, Post Falls
- Kootenai Clinic Cancer Services - Sandpoint, Sandpoint
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 30, 2026 · NCT07198074Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- at 8 pa
Nagre-recruitPhase 3
Edad 18 pataas · Kababaihan · Na-update Set 29, 2026 · NCT05256225Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- Saint Alphonsus Cancer Care Center-Boise, Boise
- Saint Luke's Cancer Institute - Boise, Boise
- Saint Alphonsus Cancer Care Center-Caldwell, Caldwell
- at 8 pa
Nagre-recruitPhase 2
Lahat ng edad · Lahat ng kasarian · Na-update Set 29, 2026 · NCT05564377Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- Saint Luke's Cancer Institute - Boise, Boise
- Kootenai Health - Coeur d'Alene, Coeur d'Alene
- Saint Luke's Cancer Institute - Fruitland, Fruitland
- at 4 pa
Nagre-recruitPhase 2
Edad 18 pataas · Kababaihan · Na-update Set 28, 2026 · NCT05112601SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Boise
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.